Eugenio Battaglia

Eugenio Battaglia

Oct 17, 2014

Group 6 Copy 228
-1
    Please wait...

    About This Project

    BioPeers – Peers Center for Biotech and Society
    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Early-Stage Drug Discovery for Chagas' Disease

    An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan...

    Community-based Leishmaniasis research in Sri Lanka

    Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

    Viral Causes of Lung Cancer

    We have special access to blood specimens collected from more than 9,000 cancer free people. These individuals...

    Backer Badge Funded